Gunapala Shetty1, Jennifer M Mitchell2, Jennifer M Meyer2, Zhuang Wu1, Truong N A Lam1, Thien T Phan1, Jie Zhang1, Lorraine Hill2, Ramesh C Tailor3, Karen A Peters4, Maria C Penedo5, Carol Hanna6, Kyle E Orwig4, Marvin L Meistrich1. 1. Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 2. Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 3. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 4. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA. 5. Veterinary Genetics Laboratory, University of California, Davis, California, USA. 6. Assisted Reproductive Technology Core, Oregon National Primate Research Center, Beaverton, Oregon, USA.
Abstract
BACKGROUND: In male pre-pubertal cancer patients, radiation and chemotherapy impact future fertility by eradication of spermatogonial stem cells (SSCs). In macaques, spermatogenesis could be regenerated by intratesticular transplantation of SSCs, but only a small percentage of spermatozoa produced were of donor origin. Transient hormone suppression with a GnRH antagonist (GnRH-ant) enhanced spermatogenic recovery from transplanted SSCs. OBJECTIVES: To evaluate donor-derived and endogenous spermatogenic recovery after SSC transplantation into irradiated monkeys and to test whether hormone suppression around the time of transplantation facilitates spermatogenic recovery. MATERIALS AND METHODS: Testes of 15 adult rhesus monkeys were irradiated with 7 Gy and 4 months later transplanted, to one of the testes, with cryopreserved testicular cells containing SSCs from unrelated monkeys. Monkeys were either treated with GnRH-ant for 8 weeks before transplantation, GnRH-ant from 4 weeks before to 4 weeks after transplantation, or with no GnRH-ant. Tissues were harvested 10 months after transplantation. RESULTS: Two of the 15 monkeys, a control and a pre-transplantation GnRH-ant-treated, showed substantially higher levels of testicular spermatogenesis and epididymal sperm output in the transplanted side as compared to the untransplanted. Over 84% of epididymal spermatozoa on the transplanted side had the donor genotype and were capable of fertilizing eggs after intracytoplasmic sperm injection forming morulae of the donor paternal origin. Low levels of donor spermatozoa (~1%) were also identified in the epididymis of three additional monkeys. Transplantation also appeared to enhance endogenous spermatogenesis. DISCUSSION AND CONCLUSION: We confirmed that SSC transplantation can be used for restoration of fertility in male cancer survivors exposed to irradiation as a therapeutic agent. The success rate of this procedure, however, is low. The success of filling the tubules with the cell suspension, but not the GnRH-ant treatment, was related to the level of colonization by transplanted cells.
BACKGROUND: In male pre-pubertal cancerpatients, radiation and chemotherapy impact future fertility by eradication of spermatogonial stem cells (SSCs). In macaques, spermatogenesis could be regenerated by intratesticular transplantation of SSCs, but only a small percentage of spermatozoa produced were of donor origin. Transient hormone suppression with a GnRH antagonist (GnRH-ant) enhanced spermatogenic recovery from transplanted SSCs. OBJECTIVES: To evaluate donor-derived and endogenous spermatogenic recovery after SSC transplantation into irradiated monkeys and to test whether hormone suppression around the time of transplantation facilitates spermatogenic recovery. MATERIALS AND METHODS: Testes of 15 adult rhesus monkeys were irradiated with 7 Gy and 4 months later transplanted, to one of the testes, with cryopreserved testicular cells containing SSCs from unrelated monkeys. Monkeys were either treated with GnRH-ant for 8 weeks before transplantation, GnRH-ant from 4 weeks before to 4 weeks after transplantation, or with no GnRH-ant. Tissues were harvested 10 months after transplantation. RESULTS: Two of the 15 monkeys, a control and a pre-transplantation GnRH-ant-treated, showed substantially higher levels of testicular spermatogenesis and epididymal sperm output in the transplanted side as compared to the untransplanted. Over 84% of epididymal spermatozoa on the transplanted side had the donor genotype and were capable of fertilizing eggs after intracytoplasmic sperm injection forming morulae of the donor paternal origin. Low levels of donor spermatozoa (~1%) were also identified in the epididymis of three additional monkeys. Transplantation also appeared to enhance endogenous spermatogenesis. DISCUSSION AND CONCLUSION: We confirmed that SSC transplantation can be used for restoration of fertility in male cancer survivors exposed to irradiation as a therapeutic agent. The success rate of this procedure, however, is low. The success of filling the tubules with the cell suspension, but not the GnRH-ant treatment, was related to the level of colonization by transplanted cells.
Authors: Cecily V Bishop; Taylor E Reiter; David W Erikson; Carol B Hanna; Brittany L Daughtry; Shawn L Chavez; Jon D Hennebold; Richard L Stouffer Journal: J Assist Reprod Genet Date: 2019-06-11 Impact factor: 3.412
Authors: Lisa B Kenney; Zoltan Antal; Jill P Ginsberg; Bradford S Hoppe; Sharon L Bober; Richard N Yu; Louis S Constine; Hanneke M van Santen; Roderick Skinner; Daniel M Green Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: A D Kirk; L C Burkly; D S Batty; R E Baumgartner; J D Berning; K Buchanan; J H Fechner; R L Germond; R L Kampen; N B Patterson; S J Swanson; D K Tadaki; C N TenHoor; L White; S J Knechtle; D M Harlan Journal: Nat Med Date: 1999-06 Impact factor: 53.440
Authors: J A Byrne; D A Pedersen; L L Clepper; M Nelson; W G Sanger; S Gokhale; D P Wolf; S M Mitalipov Journal: Nature Date: 2007-11-14 Impact factor: 49.962
Authors: Brian P Hermann; Meena Sukhwani; Chih-Cheng Lin; Yi Sheng; Jamie Tomko; Mario Rodriguez; Jennifer J Shuttleworth; David McFarland; Robin M Hobbs; Pier Paolo Pandolfi; Gerald P Schatten; Kyle E Orwig Journal: Stem Cells Date: 2007-06-21 Impact factor: 6.277
Authors: Natasha N Frederick; James L Klosky; Lillian R Meacham; Gwendolyn P Quinn; Joanne Frankel Kelvin; Brooke Cherven; David R Freyer; Christopher C Dvorak; Julienne Brackett; Sameeya Ahmed-Winston; Elyse Bryson; Eric J Chow; Jennifer Levine Journal: JCO Oncol Pract Date: 2021-10-28
Authors: Gunapala Shetty; Jennifer M Mitchell; Truong N A Lam; Thien T Phan; Jie Zhang; Ramesh C Tailor; Karen A Peters; Maria Cecilia Penedo; Carol B Hanna; Amander T Clark; Kyle E Orwig; Marvin L Meistrich Journal: Andrology Date: 2021-07-07 Impact factor: 4.456
Authors: Gabriele Matilionyte; Melissa D Tharmalingam; Iris Sanou; Federica Lopes; Sheila Lane; Jan-Bernd Stukenborg; Norah Spears; Richard A Anderson; Rod T Mitchell Journal: Front Toxicol Date: 2022-03-21